Skip to main content
. 2019 May 7;27(5):565–573. doi: 10.3727/096504018X15313896322888

Table 2.

Treatment Response to First Cycle of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE)

Parameters Patients (N = 39)
Complete response (CR) 2 (5.1)
Partial response (PR) 24 (61.5)
Overall response rate (ORR) 26 (66.7)
Stable disease (SD) 10 (25.6)
Progressive disease (PD) 2 (5.1)
Not assessed 1 (2.6)

Data are presented as count n (%).